Post-Pandemic Seroprevalence of 2009 Pandemic Influenza A (H1N1) Virus in Shandong Province, China
The purpose of this study was to understand the geographic extent, risk factors, and attack rate of the 2009 pandemic influenza A (H1N1) virus [A(H1N1)pdm09] infection in Shandong Province, China and to identify the influencing factors. A randomized serological survey of A(H1N1)pdm09 infection was c...
Saved in:
Published in | Japanese Journal of Infectious Diseases Vol. 65; no. 5; pp. 410 - 414 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee
2012
|
Subjects | |
Online Access | Get full text |
ISSN | 1344-6304 1884-2836 1884-2836 |
DOI | 10.7883/yoken.65.410 |
Cover
Abstract | The purpose of this study was to understand the geographic extent, risk factors, and attack rate of the 2009 pandemic influenza A (H1N1) virus [A(H1N1)pdm09] infection in Shandong Province, China and to identify the influencing factors. A randomized serological survey of A(H1N1)pdm09 infection was carried out in August and September 2010. A total of 4,549 participants involved in the survey had their antibody levels tested by hemagglutination-inhibition assay. The overall seropositive rate for A(H1N1)pdm09 antibodies was 25.85%. The seropositive rate was 25.89% for the unvaccinated group, with statistically significant differences among individuals of different age groups, occupations, and cities. The highest seropositive rate was observed in young children aged 0–5 years and elderly people aged ≥60 years. Multivariate logistic regression revealed that subjects in rural areas had significantly higher odds ratio of A(H1N1)pdm09 seropositivity than those in the capital city. Individuals belonging to all professions, except for teachers, had significantly lower odds ratio of A(H1N1)pdm09 seropositivity compared with children in family care. Our data indicated that almost 26% of the residents in Shandong Province had appropriate antibody titers against A(H1N1)pdm09. This seroepidemiology study provides valuable data for understanding the epidemiology of the 2009 pandemic influenza and for planning future intervention strategies; moreover, it highlights the significance of seroprevelance studies. |
---|---|
AbstractList | The purpose of this study was to understand the geographic extent, risk factors, and attack rate of the 2009 pandemic influenza A (H1N1) virus [A(H1N1)pdm09] infection in Shandong Province, China and to identify the influencing factors. A randomized serological survey of A(H1N1)pdm09 infection was carried out in August and September 2010. A total of 4,549 participants involved in the survey had their antibody levels tested by hemagglutination-inhibition assay. The overall seropositive rate for A(H1N1)pdm09 antibodies was 25.85z. The seropositive rate was 25.89z for the unvaccinated group, with statistically significant differences among individuals of different age groups, occupations, and cities. The highest seropositive rate was observed in young children aged 0-5 years and elderly people aged > or =60 years. Multivariate logistic regression revealed that subjects in rural areas had significantly higher odds ratio of A(H1N1)pdm09 seropositivity than those in the capital city. Individuals belonging to all professions, except for teachers, had significantly lower odds ratio of A(H1N1)pdm09 seropositivity compared with children in family care. Our data indicated that almost 26z of the residents in Shandong Province had appropriate antibody titers against A(H1N1)pdm09. This seroepidemiology study provides valuable data for understanding the epidemiology of the 2009 pandemic influenza and for planning future intervention strategies; moreover, it highlights the significance of seroprevelance studies. The purpose of this study was to understand the geographic extent, risk factors, and attack rate of the 2009 pandemic influenza A (H1N1) virus [A(H1N1)pdm09] infection in Shandong Province, China and to identify the influencing factors. A randomized serological survey of A(H1N1)pdm09 infection was carried out in August and September 2010. A total of 4,549 participants involved in the survey had their antibody levels tested by hemagglutination-inhibition assay. The overall seropositive rate for A(H1N1)pdm09 antibodies was 25.85%. The seropositive rate was 25.89% for the unvaccinated group, with statistically significant differences among individuals of different age groups, occupations, and cities. The highest seropositive rate was observed in young children aged 0–5 years and elderly people aged ≥60 years. Multivariate logistic regression revealed that subjects in rural areas had significantly higher odds ratio of A(H1N1)pdm09 seropositivity than those in the capital city. Individuals belonging to all professions, except for teachers, had significantly lower odds ratio of A(H1N1)pdm09 seropositivity compared with children in family care. Our data indicated that almost 26% of the residents in Shandong Province had appropriate antibody titers against A(H1N1)pdm09. This seroepidemiology study provides valuable data for understanding the epidemiology of the 2009 pandemic influenza and for planning future intervention strategies; moreover, it highlights the significance of seroprevelance studies. The purpose of this study was to understand the geographic extent, risk factors, and attack rate of the 2009 pandemic influenza A (H1N1) virus [A(H1N1)pdm09] infection in Shandong Province, China and to identify the influencing factors. A randomized serological survey of A(H1N1)pdm09 infection was carried out in August and September 2010. A total of 4,549 participants involved in the survey had their antibody levels tested by hemagglutination-inhibition assay. The overall seropositive rate for A(H1N1)pdm09 antibodies was 25.85%. The seropositive rate was 25.89% for the unvaccinated group, with statistically significant differences among individuals of different age groups, occupations, and cities. The highest seropositive rate was observed in young children aged 0-5 years and elderly people aged ≥60 years. Multivariate logistic regression revealed that subjects in rural areas had significantly higher odds ratio of A(H1N1)pdm09 seropositivity than those in the capital city. Individuals belonging to all professions, except for teachers, had significantly lower odds ratio of A(H1N1)pdm09 seropositivity compared with children in family care. Our data indicated that almost 26% of the residents in Shandong Province had appropriate antibody titers against A(H1N1)pdm09. This seroepidemiology study provides valuable data for understanding the epidemiology of the 2009 pandemic influenza and for planning future intervention strategies; moreover, it highlights the significance of seroprevelance studies.The purpose of this study was to understand the geographic extent, risk factors, and attack rate of the 2009 pandemic influenza A (H1N1) virus [A(H1N1)pdm09] infection in Shandong Province, China and to identify the influencing factors. A randomized serological survey of A(H1N1)pdm09 infection was carried out in August and September 2010. A total of 4,549 participants involved in the survey had their antibody levels tested by hemagglutination-inhibition assay. The overall seropositive rate for A(H1N1)pdm09 antibodies was 25.85%. The seropositive rate was 25.89% for the unvaccinated group, with statistically significant differences among individuals of different age groups, occupations, and cities. The highest seropositive rate was observed in young children aged 0-5 years and elderly people aged ≥60 years. Multivariate logistic regression revealed that subjects in rural areas had significantly higher odds ratio of A(H1N1)pdm09 seropositivity than those in the capital city. Individuals belonging to all professions, except for teachers, had significantly lower odds ratio of A(H1N1)pdm09 seropositivity compared with children in family care. Our data indicated that almost 26% of the residents in Shandong Province had appropriate antibody titers against A(H1N1)pdm09. This seroepidemiology study provides valuable data for understanding the epidemiology of the 2009 pandemic influenza and for planning future intervention strategies; moreover, it highlights the significance of seroprevelance studies. |
Author | Song, Shaoxia Wang, Xianjun Wang, Yulu Li, Zhong Liu, Ti Zhang, Shengyang Wang, Shuang Xu, Aiqiang Lin, Yi Bi, Zhenqiang |
Author_xml | – sequence: 1 fullname: Wang, Yulu organization: Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Diseases Control and Prevention, Shandong University Institute for Prevention Medicine – sequence: 1 fullname: Xu, Aiqiang organization: Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Diseases Control and Prevention, Shandong University Institute for Prevention Medicine – sequence: 1 fullname: Zhang, Shengyang organization: Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Diseases Control and Prevention, Shandong University Institute for Prevention Medicine – sequence: 1 fullname: Wang, Shuang organization: Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Diseases Control and Prevention, Shandong University Institute for Prevention Medicine – sequence: 1 fullname: Wang, Xianjun organization: Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Diseases Control and Prevention, Shandong University Institute for Prevention Medicine – sequence: 1 fullname: Lin, Yi organization: Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Diseases Control and Prevention, Shandong University Institute for Prevention Medicine – sequence: 1 fullname: Bi, Zhenqiang organization: Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Diseases Control and Prevention, Shandong University Institute for Prevention Medicine – sequence: 1 fullname: Liu, Ti organization: Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Diseases Control and Prevention, Shandong University Institute for Prevention Medicine – sequence: 1 fullname: Song, Shaoxia organization: Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Diseases Control and Prevention, Shandong University Institute for Prevention Medicine – sequence: 1 fullname: Li, Zhong organization: Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Diseases Control and Prevention, Shandong University Institute for Prevention Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22996214$$D View this record in MEDLINE/PubMed |
BookMark | eNqF0c1rFDEYBvAgFfuhN88lxwqdNd-TnKQsagtFF6peQyZ9002dTbbJTKH-9U676woF8ZTA-3uSkOcQ7aWcAKG3lMxarfn7h_wT0kzJmaDkBTqgWouGaa72pj0XolGciH10WOstIUxKSl6hfcaMUYyKA9Qtch2ahUvXsIoeX0HJ6wL3rofkAeeAGSEG7-YXKfQjpF8On-GTc_qFvsM_YhkrjglfLSeV0w1elHwfp_gpni9jcq_Ry-D6Cm-26xH6_unjt_l5c_n188X87LLx0rChaV3QznM1PdIHqbzuoGWkNarrfCCMtsY5GoQ3mmoTghCd9IJQL3krWsEMP0Inm3PXJd-NUAe7itVD37sEeayWSi60bFtD_0-JMoxIzdREj7d07FZwbdclrlx5sH--cAKnG-BLrrVA2BFK7GND9qkhq6SdGpo4e8Z9HNwQcxqKi_2_Qh82ods6uBvY3eDKEH0Pf7HcJnYTv3TFQuK_AadvqaA |
CitedBy_id | crossref_primary_10_1007_s00705_016_2997_2 crossref_primary_10_1155_2022_5833769 |
Cites_doi | 10.1371/journal.pone.0011601 10.1371/journal.pone.0023034 10.2807/ese.14.18.19204-en 10.3201/eid1701.100014 10.1086/656922 10.1371/journal.pone.0024440 10.1016/j.vaccine.2010.03.006 10.1056/NEJMoa0911530 10.1016/S0140-6736(09)62126-7 10.1371/journal.pone.0012562 10.1186/1471-2458-10-650 10.1056/NEJMoa0906453 10.1371/journal.pone.0013211 |
ContentType | Journal Article |
Copyright | Authors |
Copyright_xml | – notice: Authors |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7T2 7U1 7U9 C1K H94 |
DOI | 10.7883/yoken.65.410 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Health and Safety Science Abstracts (Full archive) Risk Abstracts Virology and AIDS Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Risk Abstracts AIDS and Cancer Research Abstracts Health & Safety Science Abstracts Virology and AIDS Abstracts Environmental Sciences and Pollution Management |
DatabaseTitleList | Risk Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1884-2836 |
EndPage | 414 |
ExternalDocumentID | 22996214 10_7883_yoken_65_410 article_yoken_65_5_65_410_article_char_en |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | China China, People's Rep., Shandong Prov |
GeographicLocations_xml | – name: China – name: China, People's Rep., Shandong Prov |
GroupedDBID | --- .55 29J 2WC 3O- 53G 5GY 7.U ACPRK ADBBV AENEX AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL DIK DU5 E3Z EBS EJD F5P FRP GX1 JSF JSH KQ8 OK1 OVT RJT RNS RZJ TR2 W2D X7M XSB ZXP AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7T2 7U1 7U9 C1K H94 |
ID | FETCH-LOGICAL-c592t-7af8ac36025cf56c8be720796bbcf02179aa1f4c98189ff44b5c401c537474293 |
ISSN | 1344-6304 1884-2836 |
IngestDate | Thu Jul 10 18:37:02 EDT 2025 Fri Jul 11 02:47:10 EDT 2025 Mon Jul 21 06:03:49 EDT 2025 Tue Jul 01 03:55:09 EDT 2025 Thu Apr 24 23:11:50 EDT 2025 Wed Sep 03 06:30:23 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c592t-7af8ac36025cf56c8be720796bbcf02179aa1f4c98189ff44b5c401c537474293 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/yoken/65/5/65_410/_article/-char/en |
PMID | 22996214 |
PQID | 1069205826 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_1534857791 proquest_miscellaneous_1069205826 pubmed_primary_22996214 crossref_primary_10_7883_yoken_65_410 crossref_citationtrail_10_7883_yoken_65_410 jstage_primary_article_yoken_65_5_65_410_article_char_en |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-00-00 |
PublicationDateYYYYMMDD | 2012-01-01 |
PublicationDate_xml | – year: 2012 text: 2012-00-00 |
PublicationDecade | 2010 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan |
PublicationTitle | Japanese Journal of Infectious Diseases |
PublicationTitleAlternate | Jpn J Infect Dis |
PublicationYear | 2012 |
Publisher | National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee |
Publisher_xml | – name: National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee |
References | 10. European Centre for Disease Prevention and Control Technical Emergency Team (2009): Progression and impact of the first winter wave of the 2009 pandemic H1N1 influenza in New South Wales, Australia. Euro Surveillance, 14, pii=19365. 8. Zimmer, S.M., Crevar, C.J., Carter, D.M., et al. (2010): Seroprevalence following the second wave of pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PLoS ONE, 5, e11601. 5. Centers for Disease Control and Prevention (2009): Swine-origin influenza A (H1N1) virus infections in a school—New York City, April 2009. Mobid. Mortal. Wkly. Rep., 58, 470–472. 12. Xu, C., Bai, T., Iuliano, A.D., et al. (2010): The seroprevalence of pandemic influenza H1N1 (2009) virus in China. PLoS One, 6, e17919. 26. Wu, U.I., Liu, M.T., Wang, J.T., et al. (2010): Serological response to H1N1 influenza virus infections in adults treated with oseltamivir. Clin. Infect. Dis., 51, 1223–1225. 29. Hancock, K., Veguilla, V., Lu, X., et al. (2009): Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med., 361, 1945–1952. 9. Tilston, N.L., Eames, K.T., Paolotti, D., et al. (2010): Internetbased surveillance of influenza-like-illness in the UK during the 2009 H1N1 influenza pandemic. BMC Public Health, 10, 650. 31. Rizzo, C., Rota, M.C., Bella, A., et al. (2010): Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period. Vaccine, 28, 3558–3562. 28. Ross, T.M., Hairong, L., Chia, B.S., et al. (2011): Prevalence of antibodies against seasonal influenza A and B viruses during the 2009–2010 and 2010–2011 influenza seasons in residents of Pittsburgh, PA, USA. PLoS Currents Influenza, 2011 Oct 25. 30. Huang, D.T., Shao, P.L., Huang, K.C., et al. (2011): Serologic status for pandemic (H1N1) 2009 virus, Taiwan. Emerg. Infect. Dis., 17, 76–78. 14. Word Health Organization (WHO): WHO Manual on animal influenza diagnosis and surveillance WHO/CDS/CSR/NCS/2002.5. Online at 〈http://www.who.int/csr/resources/publications/influenza/whocdscsrncs20025rev.pdf〉. 22. Achonu, C., Rosella, L., Gubbay, J.B., et al. (2011): Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009–May 2010. PLoS One, 6, e26427. 24. von Kries, R., Weiss, S., Falkenhorst, G., et al. (2011): Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (swine flu) among children, 18 years in Germany. PLoS One, 6, e23955. 15. Cowling, B.J., Chan, K.H., Fang, V.J., et al. (2010): Comparative epidemiology of pandemic and seasonal influenza A in households. N. Engl. J. Med., 362, 2175–2184. 21. Zhang, X., He, J., Li, L., et al. (2011): Serologic survey of the pandemic H1N1 2009 virus in Guangdong Province, China: a cross sectional study. PLoS One, 6, e23034. 17. Bin, C., Xingwang, L., Yuelong, S., et al. (2009): National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group. Clinical and epidemiologic characteristics of 3 early cases of influenza A pandemic (H1N1) 2009 virus infection, People's Republic of China, 2009. Emerg. Infect. Dis., 15, 1418–1422. 6. World Health Organization (2009): World Now at the Start of 2009 Influenza Pandemic; statement to the press by WHO Director-General Dr Margaret Chan. Online at 〈http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/index.html〉. Accessed 15 March 2010. 13. World Health Organization Collaborating Centers for Reference and Research on Influenza and United States. Dept. of Health and Human Services (1982): Concepts and Procedures for Laboratory-Based Influenza Surveillance. p. 17–35. 11. Miller, E., Hoschler, K., Hardelid, P., et al. (2010): Incidence of 2009 pandemic influenza A H1N1 infection in England: a crosssectional serological study. Lancet, 375, 1100–1108. 2. Centers for Disease Control and Prevention (2009): Outbreak of swine-origin influenza A (H1N1) virus infection—Mexico, March–April 2009. Morbid. Mortal. Wkly. Rep., 58, 467–470. 4. European Centre for Disease Prevention and Control Technical Emergency Team (2009): Pandemic phase level 4: human cases of the novel influenza A/H1N1 strain confirmed in Scotland and Spain. Euro Surveillance, 14, pii: 19185. 19. Gilbert, G.L., Cretikos, M.A., Hueston, L., et al. (2010): Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS One, 5, e12562. 1. Centers for Disease Control and Prevention (2009): Swine influenza A (H1N1) infection in two children—Southern California, March–April 2009. Mobid. Mortal. Wkly. Rep., 58, 400–402. 18. Chen, C.J., Lee, P.I., Chang, S.C., et al. (2011): Seroprevalence and severity of 2009 pandemic influenza A H1N1 in Taiwan. PLoS ONE, 6, e24440. 32. Zhou, Y., Ng, D.M.W., Seto, W.H., et al. (2011): Seroprevalence of antibody to pandemic influenza A (H1N1) 2009 among healthcare workers after the first wave in Hong Kong. J. Hosp. Infect., 78, 308–311. 7. Wu, J.T., Ma, E.S., Lee, C.K., et al. (2010): The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin. Infect. Dis., 51, 1184–1191. 25. Prachayangprecha, S., Makkoch, J., Vuthitanachot, C., et al. (2011): Epidemiological and serological surveillance of human pandemic influenza A virus infections during 2009–2010 in Thailand. Jpn. J. Infect. Dis., 64, 377–381. 27. Hung, I.F., To, K.K., Lee, C.K., et al. (2010): Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009. Clin. Infect. Dis., 51, 274–279. 3. European Centre for Disease Prevention and Control Technical Emergency Team (2009): Initial epidemiological findings in the European Union following the declaration of pandemic alert level 5 due to influenza A (H1N1). Euro Surveillance, 14, 1–4. 23. Maltezou, H.C., Katerelos, P., Mavrouli, M., et al. (2011): Seroepidemiological study of pandemic influenza H1N1 following the 2009–2010 wave in Greece. Vaccine, 29, 6664–6669. 20. Bandaranayake, D., Huang, Q.S., Bissielo, A., et al. (2010): Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS One, 5, e13211. 16. Presanis, A.M., De Angelis, D., et al. (2009): New York City Swine Flu Investigation Team. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PloS Med., 6, e1000207. 22 23 24 25 26 27 28 10 11 12 13 14 15 16 17 18 19 1 2 3 4 5 6 7 8 9 20 21 |
References_xml | – reference: 6. World Health Organization (2009): World Now at the Start of 2009 Influenza Pandemic; statement to the press by WHO Director-General Dr Margaret Chan. Online at 〈http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/index.html〉. Accessed 15 March 2010. – reference: 17. Bin, C., Xingwang, L., Yuelong, S., et al. (2009): National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group. Clinical and epidemiologic characteristics of 3 early cases of influenza A pandemic (H1N1) 2009 virus infection, People's Republic of China, 2009. Emerg. Infect. Dis., 15, 1418–1422. – reference: 21. Zhang, X., He, J., Li, L., et al. (2011): Serologic survey of the pandemic H1N1 2009 virus in Guangdong Province, China: a cross sectional study. PLoS One, 6, e23034. – reference: 25. Prachayangprecha, S., Makkoch, J., Vuthitanachot, C., et al. (2011): Epidemiological and serological surveillance of human pandemic influenza A virus infections during 2009–2010 in Thailand. Jpn. J. Infect. Dis., 64, 377–381. – reference: 23. Maltezou, H.C., Katerelos, P., Mavrouli, M., et al. (2011): Seroepidemiological study of pandemic influenza H1N1 following the 2009–2010 wave in Greece. Vaccine, 29, 6664–6669. – reference: 31. Rizzo, C., Rota, M.C., Bella, A., et al. (2010): Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period. Vaccine, 28, 3558–3562. – reference: 26. Wu, U.I., Liu, M.T., Wang, J.T., et al. (2010): Serological response to H1N1 influenza virus infections in adults treated with oseltamivir. Clin. Infect. Dis., 51, 1223–1225. – reference: 29. Hancock, K., Veguilla, V., Lu, X., et al. (2009): Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med., 361, 1945–1952. – reference: 27. Hung, I.F., To, K.K., Lee, C.K., et al. (2010): Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009. Clin. Infect. Dis., 51, 274–279. – reference: 30. Huang, D.T., Shao, P.L., Huang, K.C., et al. (2011): Serologic status for pandemic (H1N1) 2009 virus, Taiwan. Emerg. Infect. Dis., 17, 76–78. – reference: 28. Ross, T.M., Hairong, L., Chia, B.S., et al. (2011): Prevalence of antibodies against seasonal influenza A and B viruses during the 2009–2010 and 2010–2011 influenza seasons in residents of Pittsburgh, PA, USA. PLoS Currents Influenza, 2011 Oct 25. – reference: 2. Centers for Disease Control and Prevention (2009): Outbreak of swine-origin influenza A (H1N1) virus infection—Mexico, March–April 2009. Morbid. Mortal. Wkly. Rep., 58, 467–470. – reference: 32. Zhou, Y., Ng, D.M.W., Seto, W.H., et al. (2011): Seroprevalence of antibody to pandemic influenza A (H1N1) 2009 among healthcare workers after the first wave in Hong Kong. J. Hosp. Infect., 78, 308–311. – reference: 9. Tilston, N.L., Eames, K.T., Paolotti, D., et al. (2010): Internetbased surveillance of influenza-like-illness in the UK during the 2009 H1N1 influenza pandemic. BMC Public Health, 10, 650. – reference: 11. Miller, E., Hoschler, K., Hardelid, P., et al. (2010): Incidence of 2009 pandemic influenza A H1N1 infection in England: a crosssectional serological study. Lancet, 375, 1100–1108. – reference: 7. Wu, J.T., Ma, E.S., Lee, C.K., et al. (2010): The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin. Infect. Dis., 51, 1184–1191. – reference: 14. Word Health Organization (WHO): WHO Manual on animal influenza diagnosis and surveillance WHO/CDS/CSR/NCS/2002.5. Online at 〈http://www.who.int/csr/resources/publications/influenza/whocdscsrncs20025rev.pdf〉. – reference: 19. Gilbert, G.L., Cretikos, M.A., Hueston, L., et al. (2010): Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS One, 5, e12562. – reference: 5. Centers for Disease Control and Prevention (2009): Swine-origin influenza A (H1N1) virus infections in a school—New York City, April 2009. Mobid. Mortal. Wkly. Rep., 58, 470–472. – reference: 20. Bandaranayake, D., Huang, Q.S., Bissielo, A., et al. (2010): Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS One, 5, e13211. – reference: 22. Achonu, C., Rosella, L., Gubbay, J.B., et al. (2011): Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009–May 2010. PLoS One, 6, e26427. – reference: 24. von Kries, R., Weiss, S., Falkenhorst, G., et al. (2011): Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (swine flu) among children, 18 years in Germany. PLoS One, 6, e23955. – reference: 4. European Centre for Disease Prevention and Control Technical Emergency Team (2009): Pandemic phase level 4: human cases of the novel influenza A/H1N1 strain confirmed in Scotland and Spain. Euro Surveillance, 14, pii: 19185. – reference: 18. Chen, C.J., Lee, P.I., Chang, S.C., et al. (2011): Seroprevalence and severity of 2009 pandemic influenza A H1N1 in Taiwan. PLoS ONE, 6, e24440. – reference: 13. World Health Organization Collaborating Centers for Reference and Research on Influenza and United States. Dept. of Health and Human Services (1982): Concepts and Procedures for Laboratory-Based Influenza Surveillance. p. 17–35. – reference: 15. Cowling, B.J., Chan, K.H., Fang, V.J., et al. (2010): Comparative epidemiology of pandemic and seasonal influenza A in households. N. Engl. J. Med., 362, 2175–2184. – reference: 3. European Centre for Disease Prevention and Control Technical Emergency Team (2009): Initial epidemiological findings in the European Union following the declaration of pandemic alert level 5 due to influenza A (H1N1). Euro Surveillance, 14, 1–4. – reference: 10. European Centre for Disease Prevention and Control Technical Emergency Team (2009): Progression and impact of the first winter wave of the 2009 pandemic H1N1 influenza in New South Wales, Australia. Euro Surveillance, 14, pii=19365. – reference: 1. Centers for Disease Control and Prevention (2009): Swine influenza A (H1N1) infection in two children—Southern California, March–April 2009. Mobid. Mortal. Wkly. Rep., 58, 400–402. – reference: 12. Xu, C., Bai, T., Iuliano, A.D., et al. (2010): The seroprevalence of pandemic influenza H1N1 (2009) virus in China. PLoS One, 6, e17919. – reference: 16. Presanis, A.M., De Angelis, D., et al. (2009): New York City Swine Flu Investigation Team. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PloS Med., 6, e1000207. – reference: 8. Zimmer, S.M., Crevar, C.J., Carter, D.M., et al. (2010): Seroprevalence following the second wave of pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PLoS ONE, 5, e11601. – ident: 2 – ident: 7 doi: 10.1371/journal.pone.0011601 – ident: 20 doi: 10.1371/journal.pone.0023034 – ident: 4 – ident: 3 doi: 10.2807/ese.14.18.19204-en – ident: 12 – ident: 27 doi: 10.3201/eid1701.100014 – ident: 16 – ident: 24 doi: 10.1086/656922 – ident: 17 doi: 10.1371/journal.pone.0024440 – ident: 28 doi: 10.1016/j.vaccine.2010.03.006 – ident: 9 – ident: 14 doi: 10.1056/NEJMoa0911530 – ident: 22 – ident: 5 – ident: 10 doi: 10.1016/S0140-6736(09)62126-7 – ident: 1 – ident: 11 – ident: 18 doi: 10.1371/journal.pone.0012562 – ident: 8 doi: 10.1186/1471-2458-10-650 – ident: 13 – ident: 15 – ident: 26 doi: 10.1056/NEJMoa0906453 – ident: 19 doi: 10.1371/journal.pone.0013211 – ident: 6 – ident: 21 – ident: 25 – ident: 23 |
SSID | ssj0025510 |
Score | 1.911731 |
Snippet | The purpose of this study was to understand the geographic extent, risk factors, and attack rate of the 2009 pandemic influenza A (H1N1) virus [A(H1N1)pdm09]... |
SourceID | proquest pubmed crossref jstage |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 410 |
SubjectTerms | Adolescent Adult Antibodies, Viral - blood Child Child, Preschool China - epidemiology Cross-Sectional Studies Female Humans Infant Influenza A Virus, H1N1 Subtype - immunology Influenza A Virus, H1N1 Subtype - isolation & purification Influenza Vaccines - administration & dosage Influenza, Human - epidemiology Influenza, Human - immunology Influenza, Human - virology Male Middle Aged Multivariate Analysis Odds Ratio Pandemics - statistics & numerical data Seroepidemiologic Studies Vaccination - statistics & numerical data |
Title | Post-Pandemic Seroprevalence of 2009 Pandemic Influenza A (H1N1) Virus in Shandong Province, China |
URI | https://www.jstage.jst.go.jp/article/yoken/65/5/65_410/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/22996214 https://www.proquest.com/docview/1069205826 https://www.proquest.com/docview/1534857791 |
Volume | 65 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Japanese Journal of Infectious Diseases, 2012, Vol.65(5), pp.410-414 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9QwFA66ivgiXtfxRgQFZe04vaRtHhdRB3EXwV2Yt9KEdHe8tMMyI-7-er-TpJkLjqgvnaE5bUrOl-Sck3Nh7JmiHCxFqqMmkSLKZGYiSgESmaI0SjSyiRUFOB8c5uPj7MNETJYnuja6ZK6G-uK3cSX_w1XcA18pSvYfOBteihv4D_7iCg7j-lc8pkq70YzMwOThji6ppAk6sLMVUiCdSeyF9qmrR3JRYzGAXDmOD2OyCfyYni2sU-xnMqJT6aFP1szgrOuhvnaQYLG7UtXK9ZwTzqML7_EHPkFS_zhdOEgsb9jzkNPOb5lk3fFuwfiA7uc07BNLW_apaU_Oa_-AN1F4t2jjFtSyzCKIMPnqiuuqQ3hkiZXlM3MurpvLOtR0Si9x3n017TAXww0yMGX23bI4weaaJy4qdSONdt90mV1JiiIm78_3k-ANBMUqHrm4COrs9WpXlC_aP7wmvFz9Avn9xGxXTayIcnST3fC6Bd93QLnFLpn2Nrt24L0n7jC1hhe-jhfeNZzwwkN7wAvf5y8ILS-5xQoaeI8V3mPlFbdIucuO3709ejOOfI2NSAuZzKOibspapzlGQDci16UyRTIqZK6UbkhflXUdN5mWEOxk02SZEhoquRYp9FDIMuk9ttN2rbnPuFQmVqPUyBpirsSPoSJ2VkAUdHPA9vrBq7RPQE91UL5VUERp1Cs76lUuKoz6gD0P1DOXeGULXen4EKj8dFxSCU8aWiigEevHgD3tOVdhUaWTMkwgzBV0lMtkJKB6_4FGpFkpikLGA7br2B4-ocfLg60tD9l1minOmPeI7czPFuYxxNu5emKB-Qu2aaYl |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Post-pandemic+seroprevalence+of+2009+pandemic+influenza+A+%28H1N1%29+virus+in+Shandong+Province%2C+China&rft.jtitle=Japanese+journal+of+infectious+diseases&rft.au=Liu%2C+Ti&rft.au=Li%2C+Zhong&rft.au=Song%2C+Shaoxia&rft.au=Zhang%2C+Shengyang&rft.date=2012&rft.eissn=1884-2836&rft.volume=65&rft.issue=5&rft.spage=410&rft_id=info:doi/10.7883%2Fyoken.65.410&rft_id=info%3Apmid%2F22996214&rft.externalDocID=22996214 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1344-6304&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1344-6304&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1344-6304&client=summon |